Abstract
Stillen™ has been used to treat patients with gastric mucosal ulcers and has an anti-inflammatory effect. It is well-known that neuro-inflammatory reactions are related to depression. Here we evaluated the antidepressant-like effect of Stillen™ on mice subjected to the forced swimming test (FST). Stillen™ and eupatilin (a major component of Stillen™) significantly decreased immobility times compared with the FST control group. In the Stillen™-administered group, increased levels of 5-hydroxytryptamine (serotonin) and brain-derived neurotrophic factor protein were observed in the hippocampus. Nissl bodies also increased in the hippocampus neuronal cytoplasm of the Stillen™-administered group. Stillen™ decreased levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (at the mRNA and protein levels) in the hippocampus and serum, compared with the control group. In addition, the mRNA expression of estrogen receptor-β increased after Stillen™ administration in the hippocampus. These findings suggest that Stillen™ should be viewed as a candidate antidepressant.
Similar content being viewed by others
References
Angelucci, F., S. Brenè, and A.A. Mathé. 2005. BDNF in schizophrenia, depression and corresponding animal models. Molecular psychiatry 10: 345–352.
Arai, Y.P., N. Makoto, S. Jun, U. Takahiro, M. Atsuko, S. Hiroki, O. Yusuke, M. Izumi, and S. Chiharu. 2012. Fuku shin, a Kampo diagnostic procedure, could be one of useful diagnostic tools for anxiety disorders and depression. TANG 2: e15.
Artigas, F., V. Perez, and E. Alvarez. 1994. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archives of General Psychiatry 51: 248–251.
Bauer, M., T. Bschor, A. Pfennig, P.C. Whybrow, J. Angst, M. Versiani, and H.J. Möller. 2007. WFSBP task force on unipolar depressive disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World Journal of Biological Psychiatry 8: 67–104.
Becker, D.E. 2007. Drug therapy in dental practice: general principles: Part 2 pharmacodynamic considerations. Anesthesia progress 54: 19–23.
Boldrini, M., M.D. Underwood, R. Hen, G.B. Rosoklija, A.J. Dwork, J.J. Mann, and V. Arango. 2009. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34: 2376–2389.
Brann, D.W., K. Dhandapani, C. Wakade, V.B. Mahesh, and M.M. Khan. 2007. Neurotrophic and protective actions of estrogen: basic mechanisms and clinical implications. Steroids 7: 381–405.
Cai, M., P.T. Phan, J.G. Hong, D.H. Kim, J.M. Kim, S.J. Park, X. Liu, J.E. Han, H. Park, J.W. Choi, and J.H. Ryu. 2012. The neuroprotective effect of eupatilin against ischemia/reperfusion-induced delayed neuronal damage in mice. European Journal of Pharmacology 689: 104–110.
Choi, E.J., H.M. Oh, H. Wee, C.S. Choi, S.C. Choi, K.H. Kim, W.C. Han, T.Y. Oh, S.H. Kim, and C.D. Jun. 2009. Eupatilin exhibits a novel anti-tumor activity through the induction of cell cycle arrest and differentiation of gastric carcinoma AGS cells. Differentiation 77: 412–423.
Choi, S.C., E.J. Choi, H.M. Oh, S. Lee, J.K. Lee, M.S. Lee, Y.I. Shin, S.J. Choi, J.R. Chae, K.M. Lee, W.J. Lee, J.S. Park, C.Y. Shin, T.Y. Oh, and C.D. Jun. 2006. DA-9601, a standardized extract of Artemisia asiatica, blocks TNF-alpha-induced IL-8 and CCL20 production by inhibiting p38 kinase and NF-kappaB pathways in human gastric epithelial cells. World Journal of Gastroenterology 12: 4850–4858.
Chourbaji, S., A. Urani, I. Inta, C. Sanchis-Segura, C. Brandwein, M. Zink, M. Schwaninger, and P. Gass. 2006. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiology of Diseases 23: 587–594.
Creson, T.K., P. Yuan, H.K. Manji, and G. Chen. 2009. Evidence for involvement of ERK, PI3 K, and RSK in induction of Bcl-2 by valproate. Journal of Molecular Neuroscience 37: 123–134.
Delgado, P.L. 2000. Depression: the case for a monoamine deficiency. Journal of Clinical Psychiatry 61: 7–11.
Goshen, I., T. Kreisel, O. Ben-Menachem-Zidon, T. Licht, J. Weidenfeld, T. Ben-Hur, and R. Yirmiya. 2008. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Molecular psychiatry 13: 717–728.
Hellweg, R., A. Ziegenhorn, I. Heuser, and M. Deuschle. 2008. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry 41: 66–71.
Hodes, G.E., T.E. Hill-Smith, and I. Lucki. 2010. Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice. Neuroscience Letters 484: 12–16.
Karege, F., G. Vaudan, M. Schwald, N. Perroud, and R. La Harpe. 2005. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Molecular Brain Research 136: 29–37.
Lee, S., M. Lee, and S.H. Kim. 2008. Eupatilin inhibits H(2)O(2)-induced apoptotic cell death through inhibition of mitogen-activated protein kinases and nuclear factorkappaB. Food and Chemical Toxicology 46: 2865–2870.
Leggio, G.M., S. Salomone, C. Bucolo, C. Platania, V. Micale, F. Caraci, and F. Drago. 2013. Dopamine D(3) receptor as a new pharmacological target for the treatment of depression. European Journal of Pharmacology 719: 25–33.
Levine, J., Y. Barak, K.N. Chengappa, A. Rapoport, M. Rebey, and V. Barak. 1999. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40: 171–176.
Lucca, G., C.M. Comim, S.S. Valvassori, G.Z. Réus, F. Vuolo, F. Petronilho, F. Dal-Pizzol, E.C. Gavioli, and J. Quevedo. 2009. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochemistry International 54: 358–362.
Maes, M., I. Mihaylova, M. Kubera, J.C. Leunis, and M. Geffard. 2011. IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. Journal of Affective Disorders 135: 414–418.
Massa, S.M., T. Yang, Y. Xie, J. Shi, M. Bilgen, J.N. Joyce, D. Nehama, J. Rajadas, and F.M. Longo. 2010. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. The Journal of Clinical Investigation 120: 1774–1785.
Min, S.W., N.J. Kim, N.I. Baek, and D.H. Kim. 2009. Inhibitory effect of eupatilin and jaceosidin isolated from Artemisia princeps on carrageenan-induced inflammation in mice. Journal of Ethnopharmacology 125: 497–500.
Murray, C.J., and A.D. Lopez. 1997. Global mortality, disability, and the contribution of risk factors: global Burden of Disease Study. Lancet 349: 1436–1442.
Nestler, E.J., M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia. 2002. Neurobiology of depression. Neuron 34: 13–25.
Oates, J.A. 2006. The science of drug therapy. In Goodman and Gilman’s the pharmacological basis of therapeutics, 11th ed, ed. L.L. Brunton, J.S. Lazo, and K.L. Parker, 117–136. New York: McGraw-Hill.
Porsolt, R.D., A. Bertin, and M. Jalfre. 1977. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Thérapie 229: 327–336.
Reeves, H., S. Batra, R.S. May, R. Zhang, D.C. Dahl, and X. Li. 2008. Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. Journal of Clinical Psychiatry 69: 1228–1336.
Sairanen, M., G. Lucas, P. Ernfors, M. Castrén, and E. Castrén. 2005. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. Journal of Neuroscience 25: 1089–1094.
Seo, H.J., K.K. Park, S.S. Han, W.Y. Chung, M.W. Son, W.B. Kim, and Y.J. Surh. 2002. Inhibitory effects of the standardized extract (DA-9601) of Artemisia asiatica Nakai on phorbol ester-induced ornithine decarboxylase activity, papilloma formation, cyclooxygenase-2 expression, inducible nitric oxide synthase expression and nuclear transcription factor kappa B activation in mouse skin. International Journal of Cancer 100: 456–462.
Sohrabji, F., and D.K. Lewis. 2006. Estrogen–BDNF interactions: implications for neurodegenerative diseases. Frontiers in Neuroendocrinology 27: 404–414.
Stahl, S.M. 2008. Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications, 3rd ed. Cambridge: Cambridge University Press.
Viana, A.F., I.S. Maciel, F.N. Dornelles, C.P. Figueiredo, J.M. Siqueira, M.M. Campos, and J.B. Calixto. 2010. Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. Journal of Neuroinflammation 7(98): 2094–2097.
Wager-Smith, K., and A. Markou. 2011. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neuroscience and Biobehavioral Reviews 35: 742–764.
Walf, A.A., M.E. Rhodes, and C.A. Frye. 2004. Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacology, Biochemistry and Behavior 78: 523–529.
Xiong, Z., B. Jiang, P.F. Wu, J. Tian, L.L. Shi, J. Gu, Z.L. Hu, H. Fu, F. Wang, and J.G. Chen. 2011. Antidepressant effects of a plant-derived flavonoid baicalein involving extracellular signal-regulated kinases cascade. Biological and Pharmaceutical Bulletin 34: 253–259.
Yan, H.C., H.D. Qu, L.R. Sun, S.J. Li, X. Cao, Y.Y. Fang, W. Jie, J.C. Bean, W.K. Wu, X.H. Zhu, and T.M. Gao. 2010. Fuzi polysaccharide-1 produces antidepressant-like effects in mice. International Journal of Neuropsychopharmacology 13: 623–633.
Yi, L.T., J. Li, Q. Liu, D. Geng, Y.F. Zhou, X.Q. Ke, H. Chen, and L.J. Weng. 2013. Antidepressant-like effect of oleanolic acid in mice exposed to the repeated forced swimming test. Journal of Psychopharmacology 27: 459–468.
Yrjanheikki, J., T. Tikka, R. Keinanen, G. Goldsteins, P.H. Chan, and J. Koistinaho. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proceedings of the National Academy of Sciences of the United States of America 96: 13496–13500.
Acknowledgments
This research was supported by the Academic Research fund of Hoseo University in 2014 (2014-0077).
Disclosure
No competing financial interests exist.
Author information
Authors and Affiliations
Corresponding author
Additional information
Hyun-Ja Jeong and Jeong-Hwa Kim have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Jeong, HJ., Kim, JH., Kim, NR. et al. Antidepressant effect of Stillen™. Arch. Pharm. Res. 38, 1223–1231 (2015). https://doi.org/10.1007/s12272-014-0472-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-014-0472-8